Log in

CONCORD Concord Drugs Ltd BSE · India

Concord Drugs (CONCORD) news

Concord Drugs Ltd is a public biotech or pharmaceutical company listed on BSE under the ticker CONCORD, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Concord Drugs news

We have not published a story on Concord Drugs yet. When there is news, it will appear here.

Questions about Concord Drugs

What is the ticker symbol of Concord Drugs?

Concord Drugs Ltd trades under the ticker CONCORD on BSE.

Where is Concord Drugs listed?

Concord Drugs Ltd is listed on BSE.

Which country or territory is Concord Drugs listed under?

Our directory records Concord Drugs Ltd under India.

What does Concord Drugs do?

Our directory classifies Concord Drugs Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Concord Drugs?

The ISIN recorded for Concord Drugs Ltd is INE858L01010.

Does aibio.space cover Concord Drugs?

aibio.space lists Concord Drugs Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Concord Drugs?

Companies in our directory listed in the same country and business area as Concord Drugs: Brawn Biotech, Sotac Pharmaceuticals, Vasundhara Rasayans, RPG Life Sciences, Gufic Biosciences, Wockhardt.

Investor discussion: Concord Drugs

Members talk about Concord Drugs (CONCORD). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:CONCORD on TradingView.

Listing details

Concord Drugs Ltd is a public biotech or pharmaceutical company listed on BSE under the ticker CONCORD, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Concord Drugs Ltd
Ticker
CONCORD
Listing
BSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE858L01010
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.